Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Three Medical Tech Names To Watch In Healthcare Space
Investors.com
Saturday, January 4, 2014 - 4:19pm
tags:
FONAR, devices, Cantel Medical, Cepheid
Capricor gets $12.5M upfront payment in Janssen development agreement
Yahoo/Fly on the Wall
Saturday, January 4, 2014 - 4:16pm
tags:
Capricor, Janssen, CAP-1002
Salix Pharma Completes Acquistion of Santarus
Yahoo/Zacks.com
Saturday, January 4, 2014 - 4:15pm
tags:
M&A, Salix, Santarus
Tetraphase Pharmaceuticals: A Small Cap With Big Potential
Seeking Alpha
Saturday, January 4, 2014 - 4:14pm
tags:
Tetraphase Pharmaceuticals, AstraZeneca, Cubist Pharmaceuticals, antiobiotics, Eravacycline, JNJ, Merck, Pfizer
Is Tamiflu Worth It? Britain Reconsiders a Best-Selling Flu Remedy
Bloomberg/Businessweek
Friday, January 3, 2014 - 4:06pm
tags:
Tamiflu, Roche, Great Britain
Dr Reddy's CEO for double-digit spending on R&D
Business Standard, India
Friday, January 3, 2014 - 4:05pm
tags:
India, R&D, Dr Reddy's
Boston Scientific doubled its market cap in 2013. What's in store this year?
Fierce Medical Devices
Friday, January 3, 2014 - 4:04pm
tags:
Boston Scientific, devices
AstraZeneca buys a CDK9 cancer drug portfolio
Fierce Biotech
Friday, January 3, 2014 - 1:36pm
tags:
AstraZeneca, CDK9, cancer, Probiodrug
Off-label Discussion at the CMS/FDA Summit
Coaltion for Healthcare Communication
Friday, January 3, 2014 - 1:04pm
tags:
off-label, FDA
3 Health Care Stocks Dragging The Sector Down
TheStreet.com
Friday, January 3, 2014 - 12:54pm
tags:
Illumina, Alexion, Regeneron
Buzz: If it's an Irish biopharma company, it's on analysts' M&A list
Fierce Biotech
Friday, January 3, 2014 - 12:52pm
tags:
Ireland, M&A, Elan, Warner Chilcott, Gentium, Jazz Pharmaceuticals
Amgen, UCB Drug Increases Bone Density in Phase 2 Trial
Drug Discovery and Development
Friday, January 3, 2014 - 12:50pm
tags:
UCB, Amgen, bone density, romosozumab
Merck Drops More Employees to Finance Makeover
Wall St Cheat Sheet
Friday, January 3, 2014 - 12:47pm
tags:
Merck, layoffs, restructuring
24% fewer small public biotechs today than in 2008
BIOtechNOW
Friday, January 3, 2014 - 12:45pm
tags:
biotech
Sanofi is allowing open access from Jan. 1 on out
Fierce Pharma
Friday, January 3, 2014 - 12:02pm
tags:
Sanofi, clinical trial data
Small Cap BioPharmas With Near-Term Catalysts
Seeking Alpha
Friday, January 3, 2014 - 12:00pm
tags:
Amarin, Venaxis, Progenics, Celldex Therapeutics, Relistor, Vascepa
Is Pfizer Poised to Head Higher?
Wall St Cheat Sheet
Friday, January 3, 2014 - 11:58am
tags:
Pfizer
Pharmacyclics: As Imbruvica Commercialization Begins, Sell-Off Creates Opportunity
Seeking Alpha
Friday, January 3, 2014 - 11:56am
tags:
Pharmacyclics, Imbruvica, JNJ, Roche, Celgene, Gilead Sciences, mantle cell lymphoma
Bright Prospects at Bayer
Yahoo/Zacks.com
Friday, January 3, 2014 - 11:53am
tags:
Bayer, Xarelto, Eylea, Stivarga, Adempas, Lemtrada, Xofigo
Pharma R&D Cuts Hurting U.S. Competitive Standing
Forbes
Friday, January 3, 2014 - 11:52am
tags:
R&D, New England Journal of Medicine

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.